HIV DNA in monocytes has been linked to HIV-associated neurocognitive disorders (HAND), however, characterization of monocyte subsets associated with HAND remains unclear. We completed a prospective study of antiretroviral therapy-naïve, HIV-infected Thais, with varying degrees of cognitive impairment, compared to HIVuninfected controls. Monocyte subsets' CCR2, CCR5 and CD163 expression were profiled and inflammatory markers in plasma and cerebrospinal fluid (CSF), measured. Lower numbers of CCR2 + non-classical monocytes were associated with worse neuropsychological test performance (r = 0.43, p = 0.024). CCR2 + non-classical monocyte count inversely correlated with CSF neopterin (r = − 0.43, p = 0.035) and plasma TNF-α levels (r = − 0.40, p = 0.041). These data benchmark CCR2 + non-classical monocytes as an independent index of cognitive impairment.
Introduction
The prevalence of HIV-associated neurocognitive disorder (HAND) remains high (estimated 30-50%) and persists despite plasma HIV RNA suppression with potent combination antiretroviral therapy (cART) (Tozzi et al., 2009 ). These cognitive dysfunctions range in severity, spanning from the milder deficits of asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorder (MND) to more severe deficits in HIV-associated dementia (HAD). These cognitive deficits are not only widespread but impact everyday functioning, and increase morbidity and mortality with critical public health effects (Ellis et al., 1997; Heaton et al., 2004; Ickovics et al., 2001) . To date, there are no clinically proven therapies for HAND for individuals already on stable, virologically suppressive anti-HIV regimens (Shapshak et al., 2011) Our studies and those of others have highlighted the association between monocytes and HIV neuropathogenesis. We have shown a direct association between cognitive impairment and a greater number of cells harboring HIV DNA selected from cellular populations enriched with monocytes (CD14 + ) (Kusao et al., 2012) . Recent studies from others further document that in vitro, cytosolic HIV RNA in monocytes is mandatory for subsequent microglial activation and neurotoxicity (Faissner
